James E. Wagner Cultivation (JWC) (TSXV:JWCA), is pleased to announce that it has filed an application for a patent on its next-generation aeroponic technology, named GrowthSTORM™ Dual Droplet System. The Corporation believes that its technology represents a material advancement in the field of aeroponics, presenting a more ideal environment for advanced indoor cultivation of agricultural products.
JWC believes that its GrowthSTORM™ System offers significant advantages over other cultivation techniques and the Dual Droplet modification is a further advancement over existing GrowthSTORM™ technology. Through the use of two separate nutrient solutions, delivered through two distinct systems and housed within a single enclosure, the GrowthSTORM™ Dual Droplet System achieves a better balance of air and water at the root zone, and a more controlled delivery of nutrients. This results in significant improvements in plant health, in all measurable categories. JWC plans to use the GrowthSTORM™ Dual Droplet System in its existing cultivation facility, JWC 1, and the new full-scale production facility, JWC 2. Additionally, the GrowthSTORM™ Dual Droplet System will be made available to other agriculture companies in Canada, under a licensing arrangement, for use in the commercial cultivation of cannabis and other crops.
“We believe that the GrowthSTORM™ Dual Droplet System is a substantial advancement in the field of aeroponic technology. Our unique approach establishes a new benchmark for aeroponic cultivators and firmly establishes JWC as one of the foremost aeroponic companies.” Nathan Woodworth, President and CEO.
About James E. Wagner Cultivation Corporation
JWC’s wholly-owned subsidiary is a Licensed Producer under the Cannabis Regulations (formally the Access to Cannabis for Medical Purposes Regulations (“ACMPR”)) and JWC is a premium cannabis brand, focusing on producing clean, consistent cannabis. JWC uses an advanced and proprietary aeroponic platform named GrowthSTORM™. JWC was founded as a family company, based on family values. JWC began as a collective of patients and growers under the Marihuana Medical Access Regulations (the precursor to ACMPR). Since its inception, JWC has remained focused on providing the best possible patient experience. JWC’s operations are based in Kitchener, Ontario. Learn more at www.jwc.ca
Notice regarding forward-looking statements:
This press release contains statements including forward-looking information for purposes of applicable securities laws (“forward-looking statements”) about JWC and its business and operations which include, among other things, statements regarding plant cultivation technologies, the value, performance, and potential of the GrowthSTORM™ Dual Droplet System and the potential licensing of the technology to other businesses. The forward-looking statements can be identified by the use of such words as “will”, “expected”, “approximately”, “may”, “could”, “would” or similar words and phrases. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those implied in the forward-looking statements. For example, risks include risks regarding the cannabis industry, economic factors, the equity markets generally, building permit related risks and risks associated with growth and competition as well as the risks identified in the Corporation’s Filing Statement available under the Corporation’s profile at www.sedar.com. Although JWC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and are based on current assumptions which management believes to be reasonable. The Corporation disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information about this release, please contact
Nathan Woodworth, President & CEO of JWC
Phone: (519) 594-0144 x421
George Aizpurua, Vice President of First Canadian Capital Corp.
Phone: (416) 742-5600